Place de l'antibiotherapie dans la prise en charge des exacerbations de BPCO. [Role of antibiotherapy in acute exacerbation of chronic obstructive pulmonary disease]

Détails

ID Serval
serval:BIB_24FC063746EF
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Place de l'antibiotherapie dans la prise en charge des exacerbations de BPCO. [Role of antibiotherapy in acute exacerbation of chronic obstructive pulmonary disease]
Périodique
Revue Médicale Suisse
Auteur⸱e⸱s
Cavassini  M., Calandra  T., Bridevaux  P. O.
ISSN
1660-9379 (Print)
Statut éditorial
Publié
Date de publication
04/2007
Volume
3
Numéro
106
Pages
939-42
Notes
English Abstract
Journal Article
Review --- Old month value: Apr 11
Résumé
Two thirds of the exacerbations of chronic obstructive pulmonary disease (COPD) are caused by infections of the respiratory tract. The causative microorganisms differ according to the degree of COPD severity, previous antibiotic therapy and prior bacterial infections. Antibiotics and intensification of bronchodilator therapy are the cornerstones of the management of moderate and severe exacerbations of COPD. Prompt therapy of COPD exacerbations has been shown to reduce the likelihood of hospitalisation and improve the quality of life. In this article, we have reviewed current recommendations regarding the use of antibiotics in the treatment of COPD exacerbations.
Mots-clé
Anti-Bacterial Agents/*therapeutic use Humans Pulmonary Disease, Chronic Obstructive/*drug therapy/etiology Respiratory Tract Infections/*complications/*drug therapy
Pubmed
Création de la notice
24/01/2008 21:44
Dernière modification de la notice
20/08/2019 14:03
Données d'usage